[1]
A. Menter, E. . Boh, G. Lewitt, and A. . Jacobson, “Efficacy of Brodalumab vs Ustekinumab by Prior TNFα Inhibitor Exposure: Post hoc Analysis of Two Phase 3 Psoriasis Studies”, J of Skin, vol. 5, no. 6, p. s51, Nov. 2021.